BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17020686)

  • 21. EPO--one year later. Fighting anemia in the courtroom.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early intervention with recombinant human erythropoietin therapy.
    Teehan BP; Benz RL; Sigler MH; Brown JM
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):28-34. PubMed ID: 2192414
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of recombinant erythropoietin in the treatment of the anemia of chronic renal failure.
    Eschbach JW; Haley NR; Adamson JW
    Ann N Y Acad Sci; 1989; 554():225-30. PubMed ID: 2660674
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin-II, renal anemia and hyporesponsiveness to recombinant human erythropoietin.
    Schiffl H; Bergner A
    Int J Artif Organs; 1999 Oct; 22(10):672-5. PubMed ID: 10585130
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of patients' responses to epoetin alfa therapy.
    Krantz SB
    Pharmacotherapy; 1990; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 28. Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?
    Rossert J; McClellan WM; Roger SD; Verbeelen DL
    Nephrol Dial Transplant; 2002 Mar; 17(3):359-62. PubMed ID: 11865076
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
    Schaefer RM; Schaefer L; Heidland A
    Przegl Lek; 1992; 49(1-2):41-2. PubMed ID: 1455005
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythropoietin: issues in its use as a therapeutic for the anemia of chronic renal failure.
    Eschbach JW; Adamson JW
    Blood Purif; 1990; 8(5):239-54. PubMed ID: 2091684
    [No Abstract]   [Full Text] [Related]  

  • 31. Higher haematocrit levels: do they improve patient outcomes, and are they cost effective?
    Collins AJ; Keane WF
    Nephrol Dial Transplant; 1998 Jul; 13(7):1627-9. PubMed ID: 9681700
    [No Abstract]   [Full Text] [Related]  

  • 32. EPO--one year later. Effects of EPO on nutritional status in CRF.
    Schiro KB
    Nephrol News Issues; 1990 May; 4(5):26, 34. PubMed ID: 2348876
    [No Abstract]   [Full Text] [Related]  

  • 33. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Peterlongo F; Castaigne JP; Zingraff J; Delons S
    Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin.
    Abels R
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):20-5. PubMed ID: 2192413
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of recombinant human erythropoietin [rHuEpo] in man.
    Adamson JW; Eschbach JW
    Prog Clin Biol Res; 1990; 352():505-17. PubMed ID: 2205875
    [No Abstract]   [Full Text] [Related]  

  • 36. The modality of dialysis treatment: does it influence the response to erythropoietin treatment?
    Locatelli F; Del Vecchio L; Andrulli S
    Nephrol Dial Transplant; 2001 Oct; 16(10):1971-4. PubMed ID: 11572880
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD; Shah BV
    J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.